Cash-Strapped Iomai Jumps on $189M Buyout Bid by Intercell

                   
tmcnet.com     May 13, 2008            

Shares of Iomai Corp. surged more than 117 percent after the firm agreed to be acquired by Austrian vaccines maker Intercell AG in a deal valued at about $189 million. Intercell's bid of $6.60 per share marked a hefty premium - about 126 percent - to Iomai's Monday closing price of $2.92, though... [read full story]                

Full Coverage
                   

Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen...

prnewswire.com     May 13, 2008          

Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation - Intercell AG ('Intercell') to acquire Iomai Corporation ('Iomai') in a fully recommended share/cash transaction for USD 6.60 per share of...                

comments

                   

Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen...

redorbit.com     May 13, 2008          

VIENNA, Austria and GAITHERSBURG, Md., May 12 /PRNewswire-FirstCall/ -- Intercell AG (VSE: ICLL) and Iomai Corporation announced today that they have entered into a definitive agreement pursuant to which Intercell will acquire Iomai for USD 6.60 per share representing a fully diluted equity value...                

comments

                   

Austrian vaccine maker Intercell buys Iomai

reuters.com     May 13, 2008          

WASHINGTON (Reuters) - Austrian vaccine maker Intercell said on Monday it was acquiring Maryland- based Iomai Corp , a small biotechnology company trying to develop needle-free vaccines. ... "The deal creates a leading traveler's vaccine portfolio by combining...                

comments

Intercell to Acquire Iomai

redorbit.com     May 13, 2008          

Posted on: Tuesday, 13 May 2008, 06:00 CDT Intercell and Iomai have entered into a definitive agreement pursuant to which Intercell will acquire Iomai for $6.60 per share representing a fully diluted equity value of approximately $189 million. Under the terms of the merger agreement, the...                

comments

Iomai being acquired by vaccine maker Intercell

ibtimes.com     May 13, 2008          

GAITHERSBURG, Md. (AP) - Biotechnology company Iomai Corp. said late Monday it is being bought by vaccine developer Intercell AG for about $189 million, as part of that company's effort to expand its late-stage pipeline. The $6.60-per-share deal marks a 126 percent premium from Iomai's closing...                

comments

Vaccines: Intercell Buys Iomai

redorbit.com     May 13, 2008          

Posted on: Tuesday, 13 May 2008, 12:00 CDT Intercell has acquired Iomai for $189 million, in a deal motivated by the Austrian company's desire to gain ownership of Iomai's traveler's diarrhea vaccine and transdermal delivery technology. With the potential to deliver both vaccine and adjuvant,...                

comments

Intercell Patches Into Iomai

forbes.com     May 13, 2008          

Hoping to inject its late-stage pipeline with some fresh prospects, Intercell is planning to acquire the needle-free immunization developer, Iomai, for $189.0 million, or $6.60 a share. Shares of Iomai (nasdaq: )'s deal values Iomai's stock at a 126.0% premium to Monday's closing price of $2.92 a...                

comments

Iomai shares surge on premium buyout offer

ibtimes.com     May 13, 2008          

NEW YORK (AP) - Shares of Iomai Corp. surged Tuesday after the biotechnology company said vaccine maker Intercell AG offered a buyout deal of $189 million, a sharp premium for the shares. The stock rose $3.42, more than doubling to close at $6.34, approaching Intercell's proposed buyout price of...                

comments

Intercell Hopes To Pack Pipeline With Iomai

forbes.com     May 13, 2008          

Intercell is planning to acquire the needle-free immunization developer, Iomai, for $189.0 million, or $6.60 a share, in hopes of becoming the international traveler's best friend with a new portfolio of vaccines for voyagers. Shares of Iomai (nasdaq: )'s deal values Iomai's stock at a 126.0%...                

comments

                   

OTCPicks.com: OTCPicks.com Stocks to Watch for Wednesday, May 14th AVWI, IOMI, PGPM, MBIR, SOLM,...

tmcnet.com     May 14, 2008          

Our Stocks to Watch tomorrow include ActionView International Inc. (OTCBB: AVWI), Iomai Corp. (NASD: IOMI), Pilgrim Petroleum Corp. (OTC: PGPM), MobiClear Inc. (OTCBB: MBIR), Solomon Technologies Inc. (OTCBB: SOLM) and Sino Fibre Communications Inc. (OTCBB: SFBE). ActionView International, Inc....                

comments